Merck to Acquire Terns Pharmaceuticals, Inc., Expanding Its Hematology Pipeline With TERN-701, a Novel Candidate for Chronic Myeloid Leukemia (CML)

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, and Terns Pharmaceuticals, Inc. ("Terns") (Nasdaq: ...

Merck & Co., Inc. to Acquire Terns Pharmaceuticals, Inc., Expanding Its Hematology Pipeline With TERN-701, a Novel Candidate for Chronic Myeloid Leukemia (CML)

Terns' lead candidate TERN-701 is an investigational oral allosteric BCR:ABL1 tyrosine kinase inhibitor currently in Phase 1/2 development for certain patients with CML Merck to hold investor call at ...
KTEN

Mom’s menopause hot flashes leads to brain tumor diagnosis

A mom put her hot flushes and "tingling sensation" down to the menopause - until scans revealed she had 10 brain tumors.